RxDoctor Payments Data

George Garrett, MD

Family Medicine · Hope, ARNPI 1528052784

Payments from drug & device makers

$208in general payments, 2019–2025

Across 14 payments — averaging $14.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$43
  • AstraZeneca$34
  • Johnson & Johnson$25
  • Idorsia Pharmaceuticals US Inc$23
  • Silk Road Medical, Inc.$21
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$19
  • plus $43 from 3 others

What the payments were for

  • Food & beverage$208100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$208 in reported general payments places this provider in the 30th percentile of 1,347 family medicine providers in Arkansas.

See all family medicine providers in Arkansas

Medicare billing

Part B allowed, 2024
$53,515
Medicare patients
334
Services billed
1,213

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban250$179,818
JardianceEmpagliflozin129$113,263
OzempicSemaglutide81$101,557
JanuviaSitagliptin Phosphate58$54,760
MounjaroTirzepatide48$51,663
XareltoRivaroxaban35$26,254
Trelegy ElliptaFluticasone/Umeclidin/Vilanter24$18,631
TrulicityDulaglutide15$18,122
Breztri AerosphereBudesonide/Glycopyr/Formoterol16$12,798
Breo ElliptaFluticasone/Vilanterol16$9,789
JanumetSitagliptin Phos/Metformin Hcl13$8,551
SymbicortBudesonide/Formoterol Fumarate25$7,866
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen344$7,194
Gabapentin549$6,968
Lantus SolostarInsulin Glargine,hum.Rec.Anlog33$6,687

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$16$69,78563 claims
GSKTrelegy Ellipta, Breo Ellipta, Arnuity Ellipta$15$31,00752 claims
Johnson & JohnsonXarelto$25$26,25435 claims
AstraZenecaBreztri Aerosphere, Symbicort$34$20,66441 claims
AbbVieSynthroid$43$3,57344 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 30th percentile of 1,347 family medicine providers in Arkansas.

Other family medicine in Hope

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →